Ann’s over 25 years of executive experience in the pharmaceutical and biotechnology industry brings a wealth of hands-on expertise and knowledge in business development, partnerships, and strategies to expedite the commercialization process. A large part of her career has been spent with Johnson & Johnson. Ann worked at J&J’s Janssen-Ortho as Vice-President Marketing and Sales, in their Biotech and Oncology business units and the New Product Development group. She was also was a long serving member of their Executive Management Board. Ann established J & J’s biotechnology business unit and was the creative marketing force behind their most successful commercial launch and Canada’s largest biotechnology drug, EPREX, with revenues in excess of $100 million. She has extensive experience working with clinical and academic administration at the most senior level including a significant initiative with Hospital CEOs in Ontario. Ann has actively supported the Canadian biotechnology industry, both as a past board member of BIOTECanada and continues to have an excellent understanding of the current policy environment through her involvement in numerous government and Ontario biotechnology task forces and committees. Ann is located in Toronto but is always looking for an excuse to travel to BC to work with clients and to spend time at their apartment in Whistler.